Clinical Immunology, 1521-6616

Journal

More filtering options
  1. 1994
  2. Prevention of joint destruction in antigen-induced arthritis

    Frank Wollheim, Telhag, H., Henricsson, A. & Pierre Geborek, 1994, In : Clinical Immunology and Immunopathology. 70, 1, p. 19-21

    Research output: Contribution to journalArticle

  3. 1995
  4. STRUCTURAL BASIS FOR X-LINKED AGAMMAGLOBULINEMIA (XLA) - MUTATIONS AT INTERACTING BTK RESIDUES R562, W563, AND A582

    MANIAR, HS., Mauno Vihinen, WEBSTER, ADB., NILSSON, L. & SMITH, CIE., 1995, In : Clinical Immunology and Immunopathology. 76, 3, p. S198-S202

    Research output: Contribution to journalArticle

  5. 2000
  6. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency

    Mauno Vihinen, Villa, A., Mella, P., Schumacher, RF., Savoldi, G., O'Shea, JJ., Candotti, F. & Notarangelo, LD., 2000, In : Clinical Immunology. 96, 2, p. 108-118

    Research output: Contribution to journalArticle

  7. 2006
  8. Age-dependent loss of tolerance to an immunodominant epitope of glutamic acid decarboxylase in diabetic-prone RIP-B7/DR4 mice.

    Gebe, J. A., Unrath, K. A., Falk, B. A., Kouichi, I., Wen, L., Daniels, T. L., Åke Lernmark & Nepom, G. T., 2006, In : Clinical Immunology. 121, 3, p. 294-304

    Research output: Contribution to journalArticle

  9. 2007
  10. Anguish over angiopathy: Hemolytic uremic syndrome.

    Anna Blom, Diana Karpman, Goodship, T. & Sullivan, K. E., 2007, In : Clinical Immunology. 122, 2, p. 135-138

    Research output: Contribution to journalArticle

  11. C1q deficiency in an Inuit family: Identification of a new class of C1q disease-causing mutations

    Marquart, H. V., Schejbel, L., Sjöholm, A., Mårtensson, U., Nielsen, S., Koch, A., Svejgaard, A. & Garred, P., 2007, In : Clinical Immunology. 124, 1, p. 33-40

    Research output: Contribution to journalArticle

  12. 2008
  13. Restricted immunoglobulin constant heavy G chain genes in primary immunodeficiencies.

    Oxelius, V-A., Ochs, H. D. & Hammarström, L., 2008, In : Clinical Immunology. 128, p. 190-198

    Research output: Contribution to journalArticle

  14. Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens

    Hirai, H., Miura, J., Hu, Y., Helena Larsson, Larsson, K., Åke Lernmark, Sten Ivarsson, Wu, T., Kingman, A., Tzioufas, A. G. & Notkins, A. L., 2008, In : Clinical Immunology. 127, 3, p. 366-374

    Research output: Contribution to journalArticle

  15. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid

    Di Zenzo, G., Thoma-Uszynski, S., Fontao, L., Calabresi, V., Hofmann, S. C., Thomas Hellmark, Sebbag, N., Pedicelli, C., Sera, F., Lacour, J. P., Wieslander, J., Bruckner-Tuderman, L., Borradori, L., Zambruno, G. & Hertl, M., 2008 Sep, In : Clinical Immunology. 128, 3, p. 415-426

    Research output: Contribution to journalArticle

  16. 2009
  17. Distinct Temporal Evolution of TLR-mediated Dendritic Cell Cytokine Secretion in Patients with Limitied and Diffuse Cutaneous Systemic Sclerosis

    van Bon, L., Popa, C., Huijbens, R., Vonk, M., York, M., Simms, R., Roger Hesselstrand, Dirk Wuttge, Lafyatis, R. & Radstake, T., 2009, In : Clinical Immunology. 131, p. S153-S154

    Research output: Contribution to journalPublished meeting abstract

  18. The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes

    Radstake, T., van Bon, L., Broen, J., Hussiani, A., Roger Hesselstrand, Dirk Wuttge, Deng, Y., Simms, R., Lubberts, E. & Lafyatis, R., 2009, In : Clinical Immunology. 131, p. S124-S125

    Research output: Contribution to journalPublished meeting abstract

  19. The Role of X Chromosome Gene Dosage in Immune Responses

    Uvebrant, T., Svensson, J. & Corrado Cilio, 2009, In : Clinical Immunology. 131, p. S103-S104

    Research output: Contribution to journalPublished meeting abstract

  20. 2012
  21. Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.

    Jönsson, G., Lood, C., Birgitta Gullstrand, Holmström, E. M., Selander, B., Braconier, J. H., Sturfelt, G., Anders Bengtsson & Lennart Truedsson, 2012, In : Clinical Immunology. 144, 3, p. 214-227

    Research output: Contribution to journalArticle

  22. 2013
  23. Human immunoglobulin constant heavy G chain (IGHG) (Fcγ) (GM) genes, defining innate variants of IgG molecules and B cells, have impact on disease and therapy.

    Oxelius, V-A. & Pandey, J. P., 2013, In : Clinical Immunology. 149, 3, p. 475-486

    Research output: Contribution to journalReview article

  24. 2014
  25. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.

    Ohlsson, S., Petrus Linge, Birgitta Gullstrand, Lood, C., Johansson, Å., Sophie Ohlsson, Lundqvist, A., Anders Bengtsson, Carlsson, F. & Thomas Hellmark, 2014, In : Clinical Immunology. 152, 1-2, p. 10-19

    Research output: Contribution to journalArticle

  26. 2016
  27. 2019
  28. Taming hemodialysis-induced inflammation: Are complement C3 inhibitors a viable option?

    Mastellos, D. C., Reis, E. S., Ali Reza Biglarnia, Waldman, M., Quigg, R. J., Huber-Lang, M., Seelen, M. A., Daha, M. R. & Lambris, J. D., 2019, In : Clinical Immunology. 198, p. 102-105

    Research output: Contribution to journalArticle